Skip to main content

Table 1 Results of the analyzed parameters in the allergy sub-groups and the control group

From: Clara cell protein in nasal lavage fluid and nasal nitric oxide - biomarkers with anti-inflammatory properties in allergic rhinitis

 

Allergy sub-groups

Control

Group

 

persistenta

(n = 13)

intermittentb

(n = 5)

groupc

(n = 7)

differences

Combined scores of: rhinitis symptoms

2.3 ± 2.8

0.7 ± 1.5

0.4 ± 1.1

a/c p = 0.06

bronchial symptoms

0.6 ± 1.3

0.0

0.0

n.s.

Levels of:

    

CC16 (OD)

15 ± 9

18 ± 12

11 ± 9

n.s.

nNO (ppb)

70 ± 34

63 ± 30

79 ± 33

n.s.

eNO (ppb)

38 ± 41

13 ± 8

13 ± 5

a/b p = 0.06

a/c p = 0.05

Number of subjects:

    

MCpos /MCneg

7/6

2/3

0/7

(a+b)/c p = 0.03

Eospos /Eosneg

9/4

2/3

2/4

n.s.

  1. Symptom scores, levels of CC16, nNO and eNO and the number of subjects with/without demonstrable metachromatic cells (MCpos/MCneg) and eosinophils (Eospos/Eosneg) in the allergy sub-groups and the control group. OD: optical density.